D. Long

发表

Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities

P. Earl, C. Broder, R. Doms, 1994, Journal of virology.

Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies.

P. Earl, C. Broder, R. Doms, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Effect of monoclonal antibodies on limited proteolysis of native glycoprotein gD of herpes simplex virus type 1

D. Long, R. Eisenberg, G. Cohen, 1982, Journal of virology.

Interaction of human immunodeficiency virus type 1 envelope protein with liposomes containing galactosylceramide

R. Doms, D. Long, J. Berson, 1996 .

Amino-terminal sequence of glycoprotein D of herpes simplex virus types 1 and 2

D. Long, R. Eisenberg, G. Cohen, 1984, Journal of virology.

Expression of herpes simplex virus type 1 glycoprotein D deletion mutants in mammalian cells

J. Levin, D. Long, R. Eisenberg, 1988, Journal of virology.

An Adjuvanted Herpes Simplex Virus 2 Subunit Vaccine Elicits a T Cell Response in Mice and Is an Effective Therapeutic Vaccine in Guinea Pigs

D. Long, D. Bernstein, R. Cardin, 2013, Journal of Virology.

Immune responses elicited by the GEN-003 candidate HSV-2 therapeutic vaccine in a randomized controlled dose-ranging phase 1/2a trial.

D. Long, S. Hetherington, M. Škoberne, 2016, Vaccine.

Cell-cell fusion assay to study role of chemokine receptors in human immunodeficiency virus type 1 entry.

R. Doms, D. Long, J. Rucker, 1997, Methods in enzymology.

Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide

R. Doms, D. Long, J. Berson, 1994, Journal of virology.

Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.

D. Long, J. Eldridge, L. A. Boutilier, 2007, Vaccine.

A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains

R. Doms, D. Long, F. Jirik, 1996, Journal of virology.

Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody

D. Long, R. Eisenberg, G. Cohen, 1982, Journal of virology.

Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D.

D. Long, S. Udem, C. Parks, 2007, Vaccine.

Synthesis and processing of glycoproteins gD and gC of herpes simplex virus type 1

D. Long, R. Eisenberg, G. Cohen, 1980, Journal of virology.

Direct demonstration that the abundant 6-kilobase herpes simplex virus type 1 mRNA mapping between 0.23 and 0.27 map units encodes the major capsid protein VP5

D. Long, R. Eisenberg, G. Cohen, 1984, Journal of virology.

Structural and functional studies of herpes simplex virus glycoprotein D.

D. Long, R. Eisenberg, G. Cohen, 1992, Advances in experimental medicine and biology.

Identification of novel virus-specific antigens by CD4⁺ and CD8⁺ T cells from asymptomatic HSV-2 seropositive and seronegative donors.

Todd M. Gierahn, D. Long, G. Siber, 2014, Virology.

Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2

D. Long, R. Eisenberg, G. Cohen, 1984, Infection and immunity.

Disulfide bond structure of glycoprotein D of herpes simplex virus types 1 and 2

D. Long, R. Eisenberg, G. Cohen, 1992, Journal of virology.

Severe viral respiratory infections in children with IFIH1 loss-of-function mutations

D. Long, J. Fellay, A. Telenti, 2017, Proceedings of the National Academy of Sciences.

Changes in a murine leukemia virus (MLV) receptor encoded by an alphavirus vector during passage in cells expressing the MLV envelope.

D. Long, J. Silver, Y. Kazachkov, 2000, Virology.

Herpes Simplex Virus Type 2 UL24 Gene Is a Virulence Determinant in Murine and Guinea Pig Disease Models

D. Long, D. Cooper, T. Zamb, 2005, Journal of Virology.

Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody

D. Long, R. Eisenberg, G. Cohen, 1984, Journal of virology.

Glycopeptides of the Type-Common Glycoprotein gD of Herpes Simplex Virus Types 1 and 2

D. Long, R. Eisenberg, G. Cohen, 1983, Journal of virology.

Glycopeptides oftheType-Common Glycoprotein gDof HerpesSimplex Virus Types1and2

D. Long, 1983 .

Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge

D. Long, C. Heilman, R. Eisenberg, 1985, Journal of virology.

Localization of epitopes of herpes simplex virus type 1 glycoprotein D

Eisenberg, D. Long, R. Eisenberg, 1985, Journal of virology.

Development of a high-throughput β-Gal-based neutralization assay for quantitation of herpes simplex virus-neutralizing antibodies in human samples.

D. Long, R. Belshe, L. Morrison, 2016, Vaccine.

Cysteine mutants of herpes simplex virus type 1 glycoprotein D exhibit temperature-sensitive properties in structure and function

D. Long, R. Eisenberg, G. Cohen, 1990, Journal of virology.

A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection.

D. Long, H. Friedman, J. Flechtner, 2019, Vaccine.

The contribution of cysteine residues to antigenicity and extent of processing of herpes simplex virus type 1 glycoprotein D

D. Long, R. Eisenberg, G. Cohen, 1988, Journal of virology.

TheContribution ofCysteine Residues toAntigenicity andExtentof Processing ofHerpesSimplex VirusType1 Glycoprotein D

D. Long, 1988 .

Development of a high-throughput β-Gal-based neutralization assay for quantitation of herpes simplex virus-neutralizing antibodies in human samples.

Michael P. Cooney, D. Long, R. Belshe, 2016, Vaccine.

Characterization ofHumanImmunodeficiency VirusType1 gpl20Binding toLiposomes Containing Galactosylceramide

R. Doms, D. Long, 1994 .